Literature DB >> 2702777

Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.

J R Murphy1, S S Wasserman, S Baqar, L Schlesinger, C Ferreccio, A A Lindberg, M M Levine.   

Abstract

Experiments were performed in Baltimore, Maryland and in Santiago, Chile, to determine the level of Salmonella typhi antigen-driven in vitro lymphocyte replication response which signifies specific acquired immunity to this bacterium and to determine the best method of data analysis and form of data presentation. Lymphocyte replication was measured as incorporation of 3H-thymidine into desoxyribonucleic acid. Data (ct/min/culture) were analyzed in raw form and following log transformation, by non-parametric and parametric statistical procedures. A preference was developed for log-transformed data and discriminant analysis. Discriminant analysis of log-transformed data revealed 3H-thymidine incorporation rates greater than 3,433 for particulate S. typhi, Ty2 antigen stimulated cultures signified acquired immunity at a sensitivity and specificity of 82.7; for soluble S. typhi O polysaccharide antigen-stimulated cultures, ct/min/culture values of greater than 1,237 signified immunity (sensitivity and specificity 70.5%).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702777      PMCID: PMC1542130     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  CONTROLLED FIELD TRIAL IN BRITISH GUIANA SCHOOL CHILDREN OF HEAT-KILLED-PHENOLIZED AND ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES.

Authors:  M T ASHCROFT; J M RITCHIE; C C NICHOLSON
Journal:  Am J Hyg       Date:  1964-03

2.  A controlled field trial and laboratory study of five typhoid vaccines in the USSR.

Authors:  L B Hejfec; L V Salmin; M Z Lejtman; M L Kuz'minova; A V Vasil'eva; L A Levina; T G Bencianova; E A Pavlova; A A Antonova
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

3.  Immunization of man with salmonella vaccine and tetanus-diphtheria vaccine. Dose-response relationship, secondary response, and competition of antigens.

Authors:  H A Clasener
Journal:  J Hyg (Lond)       Date:  1967-12

4.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

5.  Typhoid in the United States and the risk to the international traveler.

Authors:  D N Taylor; R A Pollard; P A Blake
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

6.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.

Authors:  M H Wahdan; C Sérié; Y Cerisier; S Sallam; R Germanier
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

7.  Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.

Authors:  R H Gilman; R B Hornick; W E Woodard; H L DuPont; M J Snyder; M M Levine; J P Libonati
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

8.  Humoral and cellular immunity in typhoid and paratyphoid carrier state, investigated by means of quantitative immunoelectrophoresis and in vitro stimulation of blood lymphocytes.

Authors:  F Espersen; H H Mogensen; N Høiby; L Høj; J Greibe; S N Rasmussen; K Gaarslev
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-12

9.  Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays.

Authors:  J A Robertsson; C Fossum; S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Diagnostic value of the Widal test in areas endemic for typhoid fever.

Authors:  M M Levine; O Grados; R H Gilman; W E Woodward; R Solis-Plaza; W Waldman
Journal:  Am J Trop Med Hyg       Date:  1978-07       Impact factor: 2.345

View more
  5 in total

Review 1.  Immunology of gut mucosal vaccines.

Authors:  Marcela F Pasetti; Jakub K Simon; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

2.  Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.

Authors:  J Y Wang; F R Noriega; J E Galen; E Barry; M M Levine
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Human cell-mediated immune responses to antigenic fractions of Salmonella typhi.

Authors:  C Pérez; G M Calderón; C Ximénez; E I Melendro
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

4.  Immunogenicity of Salmonella typhi Ty21a vaccine for young children.

Authors:  J R Murphy; L Grez; L Schlesinger; C Ferreccio; S Baqar; C Muñoz; S S Wasserman; G Losonsky; J G Olson; M M Levine
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 5.  Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward.

Authors:  Marcelo B Sztein; Rosangela Salerno-Goncalves; Monica A McArthur
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.